TOWARDS Study: Xenograft Engraftment Predicts Poor Survival in TNBC

Naoto T. Ueno, Director at University of Hawaii Cancer Center, shared a post on X, about a recent paper published in JCO Precision Oncology:

TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer.

Authors: Christos Vaklavas, Cindy B. Matsen, Zhengtao Chu, Kenneth M. Boucher, Sandra D. Scherer, Satya Pathi, Anna Beck, Kirstyn E. Brownson, Saundra S. Buys, Namita Chittoria, Elyse D’Astous, H. Evin Gulbahce, N. Lynn Henry, Stephen Kimani, Jane Porretta, Regina Rosenthal, John Ward, Mei Wei, Bryan E. Welm, Alana L. Welm.

”A fascinating result is that engraftment to develop PDX predicts the response to systemic treatment in patients with triple-negative breast cancer. This is an article by a great cancer biologist, Alana Welm.”

Source: Naoto T. Ueno/X